Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia

NCT01218906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2018-01-16

No results posted yet for this study

Summary

The purpose of this study is to detect acute febrile episodes and dengue infection in five Asian countries, to assess dengue seroprevalence, and to assess surveillance infrastructure at investigational sites in anticipation of a Phase 3 efficacy trial of a vaccine to prevent dengue infection.

The primary objectives are:

* To identify acute febrile episodes among the cohort in order to detect the presence of dengue infection.
* To develop operational infrastructure for potential Phase III dengue efficacy trial sites.
* To describe the dengue seroprevalence among the cohort at baseline and at the end of the study.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Sanofi Pasteur SA.

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-11-30
Completion
2012-03-31

Countries

  • Indonesia
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01218906 on ClinicalTrials.gov